GALWAY, IRELAND--December 27, 2024--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--U.S. pharmaceutical company BioMarin Pharmaceutical (NYSE:BMRN) (San Rafael, California) has announced plans for a US$63 million expansion of its European manufacturing plant in Cork, Ireland. Within this article: Details expansion of Cork-based manufacturing operation by U.S. pharmaceutical company BioMarin Pharmaceutical, goals, products, previous investment, Irish pharma sector
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×Contact Us
For More Info!
